speb/financial-data huggingface dataset:
GUFICBIO.NS income_statement (annual, 2025-03-31) — Other Operating Expenses: 1833612000.00
GUFICBIO.NS income_statement (quarterly, 2025-03-31) — Other Operating Expenses: 534045000.00
GUFICBIO.NS balance_sheet (annual, 2025-03-31) — Other Payable: 303642000.00
GUFICBIO.NS balance_sheet (quarterly, 2025-03-31) — Other Payable: 303642000.00
GUFICBIO.NS balance_sheet (annual, 2025-03-31) — Other Properties: 200357000.00
GUFICBIO.NS balance_sheet (quarterly, 2025-03-31) — Other Properties: 200357000.00
GUFICBIO.NS balance_sheet (annual, 2025-03-31) — Other Receivables: 3221000.00
GUFICBIO.NS balance_sheet (quarterly, 2025-03-31) — Other Receivables: 3221000.00
GUFICBIO.NS balance_sheet (annual, 2025-03-31) — Other Short Term Investments: 132989000.00
GUFICBIO.NS balance_sheet (quarterly, 2025-03-31) — Other Short Term Investments: 132989000.00
GUFICBIO.NS income_statement (annual, 2025-03-31) — Other Special Charges: -1159000.00
GUFICBIO.NS income_statement (annual, 2025-03-31) — Otherunder Preferred Stock Dividend: 0.00
GUFICBIO.NS income_statement (quarterly, 2025-03-31) — Otherunder Preferred Stock Dividend: 0.00
GUFICBIO.NS balance_sheet (annual, 2025-03-31) — Payables: 1891321000.00
GUFICBIO.NS balance_sheet (quarterly, 2025-03-31) — Payables: 1891321000.00
GUFICBIO.NS balance_sheet (annual, 2025-03-31) — Prepaid Assets: 619404000.00
GUFICBIO.NS balance_sheet (quarterly, 2025-03-31) — Prepaid Assets: 619404000.00
GUFICBIO.NS income_statement (annual, 2025-03-31) — Pretax Income: 941434000.00
GUFICBIO.NS income_statement (quarterly, 2025-03-31) — Pretax Income: 105249000.00
GUFICBIO.NS balance_sheet (annual, 2025-03-31) — Properties: 0.00
GUFICBIO.NS balance_sheet (quarterly, 2025-03-31) — Properties: 0.00
GUFICBIO.NS cash_flow (annual, 2025-03-31) — Purchase Of Business: 0.00
GUFICBIO.NS cash_flow (annual, 2025-03-31) — Purchase Of Investment: 0.00
GUFICBIO.NS cash_flow (annual, 2025-03-31) — Purchase Of PPE: -755255000.00
GUFICBIO.NS balance_sheet (annual, 2025-03-31) — Raw Materials: 883004000.00
GUFICBIO.NS balance_sheet (quarterly, 2025-03-31) — Raw Materials: 883004000.00
GUFICBIO.NS income_statement (annual, 2025-03-31) — Reconciled Cost Of Revenue: 3747011000.00
GUFICBIO.NS income_statement (quarterly, 2025-03-31) — Reconciled Cost Of Revenue: 896676000.00
GUFICBIO.NS income_statement (annual, 2025-03-31) — Reconciled Depreciation: 210646000.00
GUFICBIO.NS income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 78434000.00
GUFICBIO.NS income_statement (annual, 2025-03-31) — Rent And Landing Fees: 17462000.00
GUFICBIO.NS income_statement (annual, 2025-03-31) — Rent Expense Supplemental: 17462000.00
GUFICBIO.NS cash_flow (annual, 2025-03-31) — Repayment Of Debt: -235468000.00
GUFICBIO.NS income_statement (annual, 2025-03-31) — Research And Development: 56101000.00
GUFICBIO.NS balance_sheet (annual, 2025-03-31) — Restricted Cash: 132989000.00
GUFICBIO.NS balance_sheet (quarterly, 2025-03-31) — Restricted Cash: 132989000.00
GUFICBIO.NS balance_sheet (annual, 2025-03-31) — Retained Earnings: 4209964000.00
GUFICBIO.NS balance_sheet (quarterly, 2025-03-31) — Retained Earnings: 4209964000.00
GUFICBIO.NS cash_flow (annual, 2025-03-31) — Sale Of Business: 12000.00
GUFICBIO.NS cash_flow (annual, 2025-03-31) — Sale Of PPE: 47669000.00
GUFICBIO.NS income_statement (annual, 2025-03-31) — Selling And Marketing Expense: 18626000.00
GUFICBIO.NS income_statement (annual, 2025-03-31) — Selling General And Administration: 262384000.00
GUFICBIO.NS balance_sheet (annual, 2025-03-31) — Share Issued: 100277506.00
GUFICBIO.NS balance_sheet (quarterly, 2025-03-31) — Share Issued: 100277506.00
GUFICBIO.NS cash_flow (annual, 2025-03-31) — Short Term Debt Issuance: 168036000.00
GUFICBIO.NS income_statement (annual, 2025-03-31) — Special Income Charges: 0.00
GUFICBIO.NS income_statement (quarterly, 2025-03-31) — Special Income Charges: 0.00
GUFICBIO.NS cash_flow (annual, 2025-03-31) — Stock Based Compensation: 1041000.00
GUFICBIO.NS balance_sheet (annual, 2025-03-31) — Stockholders Equity: 6010768000.00
GUFICBIO.NS balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 6010768000.00
GUFICBIO.NS balance_sheet (annual, 2025-03-31) — Tangible Book Value: 5947325000.00
GUFICBIO.NS balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: 5947325000.00
GUFICBIO.NS income_statement (annual, 2025-03-31) — Tax Effect Of Unusual Items: 0.00
GUFICBIO.NS income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: 0.00
GUFICBIO.NS income_statement (annual, 2025-03-31) — Tax Provision: 244947000.00
GUFICBIO.NS income_statement (quarterly, 2025-03-31) — Tax Provision: 28054000.00
GUFICBIO.NS income_statement (annual, 2025-03-31) — Tax Rate For Calcs: 0.26
GUFICBIO.NS income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.27
GUFICBIO.NS balance_sheet (annual, 2025-03-31) — Taxes Receivable: 15705000.00
GUFICBIO.NS balance_sheet (quarterly, 2025-03-31) — Taxes Receivable: 15705000.00
GUFICBIO.NS cash_flow (annual, 2025-03-31) — Taxes Refund Paid: -228118000.00
GUFICBIO.NS balance_sheet (annual, 2025-03-31) — Total Assets: 11693637000.00
GUFICBIO.NS balance_sheet (quarterly, 2025-03-31) — Total Assets: 11693637000.00
GUFICBIO.NS balance_sheet (annual, 2025-03-31) — Total Capitalization: 7315764000.00
GUFICBIO.NS balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 7315764000.00
GUFICBIO.NS balance_sheet (annual, 2025-03-31) — Total Debt: 3361946000.00
GUFICBIO.NS balance_sheet (quarterly, 2025-03-31) — Total Debt: 3361946000.00
GUFICBIO.NS balance_sheet (annual, 2025-03-31) — Total Equity Gross Minority Interest: 6010768000.00
GUFICBIO.NS balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 6010768000.00
GUFICBIO.NS income_statement (annual, 2025-03-31) — Total Expenses: 7061775000.00
GUFICBIO.NS income_statement (quarterly, 2025-03-31) — Total Expenses: 1864900000.00
GUFICBIO.NS balance_sheet (annual, 2025-03-31) — Total Liabilities Net Minority Interest: 5682869000.00
GUFICBIO.NS balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 5682869000.00
GUFICBIO.NS balance_sheet (annual, 2025-03-31) — Total Non Current Assets: 5448412000.00
GUFICBIO.NS balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 5448412000.00
GUFICBIO.NS balance_sheet (annual, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 1807297000.00
GUFICBIO.NS balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 1807297000.00
GUFICBIO.NS income_statement (annual, 2025-03-31) — Total Other Finance Cost: 14907000.00
GUFICBIO.NS balance_sheet (annual, 2025-03-31) — Total Tax Payable: 0.00
GUFICBIO.NS balance_sheet (quarterly, 2025-03-31) — Total Tax Payable: 0.00
GUFICBIO.NS income_statement (annual, 2025-03-31) — Total Unusual Items: 0.00
GUFICBIO.NS income_statement (quarterly, 2025-03-31) — Total Unusual Items: 0.00
GUFICBIO.NS income_statement (annual, 2025-03-31) — Total Unusual Items Excluding Goodwill: 0.00
GUFICBIO.NS income_statement (quarterly, 2025-03-31) — Total Unusual Items Excluding Goodwill: 0.00
GUFICBIO.NS balance_sheet (annual, 2025-03-31) — Work In Process: 754829000.00
GUFICBIO.NS balance_sheet (quarterly, 2025-03-31) — Work In Process: 754829000.00
GUFICBIO.NS balance_sheet (annual, 2025-03-31) — Working Capital: 2369653000.00
GUFICBIO.NS balance_sheet (quarterly, 2025-03-31) — Working Capital: 2369653000.00
GUFICBIO.NS income_statement (quarterly, 2025-06-30) — +Operating Expense: 973687000.00
GUFICBIO.NS income_statement (quarterly, 2025-06-30) — +Total Revenue: 2237225000.00
GUFICBIO.NS income_statement (quarterly, 2025-06-30) — Basic Average Shares: 100541538.00
GUFICBIO.NS income_statement (quarterly, 2025-06-30) — Basic EPS: 1.30
GUFICBIO.NS income_statement (quarterly, 2025-06-30) — Cost Of Revenue: 1007713000.00
GUFICBIO.NS income_statement (quarterly, 2025-06-30) — Depreciation And Amortization In Income Statement: 77189000.00
GUFICBIO.NS income_statement (quarterly, 2025-06-30) — Depreciation Income Statement: 77189000.00
GUFICBIO.NS income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 100541538.00
GUFICBIO.NS income_statement (quarterly, 2025-06-30) — Diluted EPS: 1.30
GUFICBIO.NS income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: 130704000.00
GUFICBIO.NS income_statement (quarterly, 2025-06-30) — EBIT: 265077000.00
GUFICBIO.NS income_statement (quarterly, 2025-06-30) — EBITDA: 342266000.00
GUFICBIO.NS income_statement (quarterly, 2025-06-30) — Gross Profit: 1229512000.00
GUFICBIO.NS income_statement (quarterly, 2025-06-30) — Interest Expense: 92336000.00
GUFICBIO.NS income_statement (quarterly, 2025-06-30) — Interest Expense Non Operating: 92336000.00
GUFICBIO.NS income_statement (quarterly, 2025-06-30) — Minority Interests: 0.00
GUFICBIO.NS income_statement (quarterly, 2025-06-30) — Net Income: 130704000.00
GUFICBIO.NS income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: 130704000.00
GUFICBIO.NS income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: 130704000.00
GUFICBIO.NS income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: 130704000.00
GUFICBIO.NS income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: 130704000.00
GUFICBIO.NS income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: 130704000.00
GUFICBIO.NS income_statement (quarterly, 2025-06-30) — Net Interest Income: -92336000.00
GUFICBIO.NS income_statement (quarterly, 2025-06-30) — Net Non Operating Interest Income Expense: -92336000.00
GUFICBIO.NS income_statement (quarterly, 2025-06-30) — Normalized EBITDA: 342266000.00
GUFICBIO.NS income_statement (quarterly, 2025-06-30) — Normalized Income: 130704000.00
GUFICBIO.NS income_statement (quarterly, 2025-06-30) — Operating Income: 255825000.00
GUFICBIO.NS income_statement (quarterly, 2025-06-30) — Operating Revenue: 2237225000.00
GUFICBIO.NS income_statement (quarterly, 2025-06-30) — Other Non Operating Income Expenses: 9252000.00
GUFICBIO.NS income_statement (quarterly, 2025-06-30) — Other Operating Expenses: 536530000.00
GUFICBIO.NS income_statement (quarterly, 2025-06-30) — Otherunder Preferred Stock Dividend: 0.00
GUFICBIO.NS income_statement (quarterly, 2025-06-30) — Pretax Income: 172741000.00
GUFICBIO.NS income_statement (quarterly, 2025-06-30) — Reconciled Cost Of Revenue: 1007713000.00
GUFICBIO.NS income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 77189000.00
GUFICBIO.NS income_statement (quarterly, 2025-06-30) — Special Income Charges: 0.00
GUFICBIO.NS income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: 0.00
GUFICBIO.NS income_statement (quarterly, 2025-06-30) — Tax Provision: 42037000.00
GUFICBIO.NS income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.24
GUFICBIO.NS income_statement (quarterly, 2025-06-30) — Total Expenses: 1981400000.00
GUFICBIO.NS income_statement (quarterly, 2025-06-30) — Total Unusual Items: 0.00
GUFICBIO.NS income_statement (quarterly, 2025-06-30) — Total Unusual Items Excluding Goodwill: 0.00
GUFICBIO.NS income_statement (quarterly, 2025-09-30) — +Operating Expense: 1025429000.00
GUFICBIO.NS income_statement (quarterly, 2025-09-30) — +Total Revenue: 2370545000.00
GUFICBIO.NS balance_sheet (quarterly, 2025-09-30) — Accounts Payable: 1989084000.00
GUFICBIO.NS balance_sheet (quarterly, 2025-09-30) — Accounts Receivable: 3239909000.00
GUFICBIO.NS balance_sheet (quarterly, 2025-09-30) — Available For Sale Securities: 123824000.00
GUFICBIO.NS income_statement (quarterly, 2025-09-30) — Basic Average Shares: 100142857.00
GUFICBIO.NS income_statement (quarterly, 2025-09-30) — Basic EPS: 1.68
GUFICBIO.NS balance_sheet (quarterly, 2025-09-30) — Capital Lease Obligations: 227812000.00
GUFICBIO.NS balance_sheet (quarterly, 2025-09-30) — Capital Stock: 100283000.00
GUFICBIO.NS balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 745998000.00
GUFICBIO.NS balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 880788000.00
GUFICBIO.NS balance_sheet (quarterly, 2025-09-30) — Common Stock: 100283000.00
GUFICBIO.NS balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: 6311294000.00
GUFICBIO.NS balance_sheet (quarterly, 2025-09-30) — Construction In Progress: 240464000.00
GUFICBIO.NS income_statement (quarterly, 2025-09-30) — Cost Of Revenue: 1044385000.00
GUFICBIO.NS balance_sheet (quarterly, 2025-09-30) — Current Assets: 7272090000.00
GUFICBIO.NS balance_sheet (quarterly, 2025-09-30) — Current Capital Lease Obligation: 65419000.00
GUFICBIO.NS balance_sheet (quarterly, 2025-09-30) — Current Debt: 2286013000.00
GUFICBIO.NS balance_sheet (quarterly, 2025-09-30) — Current Debt And Capital Lease Obligation: 2351432000.00
GUFICBIO.NS balance_sheet (quarterly, 2025-09-30) — Current Liabilities: 4696781000.00
GUFICBIO.NS balance_sheet (quarterly, 2025-09-30) — Current Provisions: 45372000.00
GUFICBIO.NS income_statement (quarterly, 2025-09-30) — Depreciation And Amortization In Income Statement: 77730000.00
GUFICBIO.NS income_statement (quarterly, 2025-09-30) — Depreciation Income Statement: 77730000.00
GUFICBIO.NS income_statement (quarterly, 2025-09-30) — Diluted Average Shares: 100142857.00
GUFICBIO.NS income_statement (quarterly, 2025-09-30) — Diluted EPS: 1.68
GUFICBIO.NS income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: 168240000.00
GUFICBIO.NS income_statement (quarterly, 2025-09-30) — EBIT: 321886000.00
GUFICBIO.NS income_statement (quarterly, 2025-09-30) — EBITDA: 399616000.00
GUFICBIO.NS balance_sheet (quarterly, 2025-09-30) — Goodwill And Other Intangible Assets: 62659000.00
GUFICBIO.NS balance_sheet (quarterly, 2025-09-30) — Gross PPE: 5127432000.00
GUFICBIO.NS income_statement (quarterly, 2025-09-30) — Gross Profit: 1326160000.00
GUFICBIO.NS income_statement (quarterly, 2025-09-30) — Interest Expense: 95845000.00
GUFICBIO.NS income_statement (quarterly, 2025-09-30) — Interest Expense Non Operating: 95845000.00
GUFICBIO.NS balance_sheet (quarterly, 2025-09-30) — Inventory: 2296617000.00
GUFICBIO.NS balance_sheet (quarterly, 2025-09-30) — Invested Capital: 9775582000.00
GUFICBIO.NS balance_sheet (quarterly, 2025-09-30) — Investmentin Financial Assets: 123824000.00
GUFICBIO.NS balance_sheet (quarterly, 2025-09-30) — Long Term Capital Lease Obligation: 162393000.00
GUFICBIO.NS balance_sheet (quarterly, 2025-09-30) — Long Term Debt: 1178275000.00
GUFICBIO.NS balance_sheet (quarterly, 2025-09-30) — Long Term Debt And Capital Lease Obligation: 1340668000.00
GUFICBIO.NS balance_sheet (quarterly, 2025-09-30) — Long Term Provisions: 187781000.00
GUFICBIO.NS balance_sheet (quarterly, 2025-09-30) — Minority Interest: 349000.00
GUFICBIO.NS income_statement (quarterly, 2025-09-30) — Minority Interests: 14000.00
GUFICBIO.NS balance_sheet (quarterly, 2025-09-30) — Net Debt: 2718290000.00
GUFICBIO.NS income_statement (quarterly, 2025-09-30) — Net Income: 168240000.00
GUFICBIO.NS income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: 168240000.00
GUFICBIO.NS income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: 168226000.00
GUFICBIO.NS income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: 168240000.00
GUFICBIO.NS income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: 168240000.00
GUFICBIO.NS income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: 168226000.00
GUFICBIO.NS income_statement (quarterly, 2025-09-30) — Net Interest Income: -95845000.00
GUFICBIO.NS income_statement (quarterly, 2025-09-30) — Net Non Operating Interest Income Expense: -95845000.00
GUFICBIO.NS balance_sheet (quarterly, 2025-09-30) — Net PPE: 5127432000.00
GUFICBIO.NS balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: 6248635000.00
GUFICBIO.NS balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Taxes Liabilities: 117968000.00
GUFICBIO.NS income_statement (quarterly, 2025-09-30) — Normalized EBITDA: 399616000.00
GUFICBIO.NS income_statement (quarterly, 2025-09-30) — Normalized Income: 168240000.00
GUFICBIO.NS income_statement (quarterly, 2025-09-30) — Operating Income: 300731000.00
GUFICBIO.NS income_statement (quarterly, 2025-09-30) — Operating Revenue: 2370545000.00
GUFICBIO.NS balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 100282506.00
GUFICBIO.NS balance_sheet (quarterly, 2025-09-30) — Other Current Assets: 823429000.00
GUFICBIO.NS balance_sheet (quarterly, 2025-09-30) — Other Current Liabilities: 141144000.00
GUFICBIO.NS balance_sheet (quarterly, 2025-09-30) — Other Equity Interest: 6211011000.00
GUFICBIO.NS balance_sheet (quarterly, 2025-09-30) — Other Non Current Assets: 117156000.00
GUFICBIO.NS income_statement (quarterly, 2025-09-30) — Other Non Operating Income Expenses: 21155000.00
GUFICBIO.NS income_statement (quarterly, 2025-09-30) — Other Operating Expenses: 573193000.00
GUFICBIO.NS balance_sheet (quarterly, 2025-09-30) — Other Properties: 4886968000.00
GUFICBIO.NS balance_sheet (quarterly, 2025-09-30) — Other Receivables: 7091000.00
GUFICBIO.NS balance_sheet (quarterly, 2025-09-30) — Other Short Term Investments: 134790000.00
GUFICBIO.NS income_statement (quarterly, 2025-09-30) — Otherunder Preferred Stock Dividend: 0.00
GUFICBIO.NS balance_sheet (quarterly, 2025-09-30) — Payables: 1989084000.00
GUFICBIO.NS income_statement (quarterly, 2025-09-30) — Pretax Income: 226041000.00
GUFICBIO.NS income_statement (quarterly, 2025-09-30) — Reconciled Cost Of Revenue: 1044385000.00
GUFICBIO.NS income_statement (quarterly, 2025-09-30) — Reconciled Depreciation: 77730000.00
GUFICBIO.NS balance_sheet (quarterly, 2025-09-30) — Share Issued: 100282506.00
GUFICBIO.NS income_statement (quarterly, 2025-09-30) — Special Income Charges: 0.00
GUFICBIO.NS balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: 6311294000.00
GUFICBIO.NS balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: 6248635000.00
GUFICBIO.NS income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: 0.00
GUFICBIO.NS income_statement (quarterly, 2025-09-30) — Tax Provision: 57815000.00
GUFICBIO.NS income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.26
GUFICBIO.NS balance_sheet (quarterly, 2025-09-30) — Taxes Receivable: 24256000.00
GUFICBIO.NS balance_sheet (quarterly, 2025-09-30) — Total Assets: 12711077000.00
GUFICBIO.NS balance_sheet (quarterly, 2025-09-30) — Total Capitalization: 7489569000.00
GUFICBIO.NS balance_sheet (quarterly, 2025-09-30) — Total Debt: 3692100000.00
GUFICBIO.NS balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: 6311643000.00
GUFICBIO.NS income_statement (quarterly, 2025-09-30) — Total Expenses: 2069814000.00
GUFICBIO.NS balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 6399434000.00
GUFICBIO.NS balance_sheet (quarterly, 2025-09-30) — Total Non Current Assets: 5438987000.00
GUFICBIO.NS balance_sheet (quarterly, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 1702653000.00
GUFICBIO.NS balance_sheet (quarterly, 2025-09-30) — Total Tax Payable: 0.00
GUFICBIO.NS income_statement (quarterly, 2025-09-30) — Total Unusual Items: 0.00
GUFICBIO.NS income_statement (quarterly, 2025-09-30) — Total Unusual Items Excluding Goodwill: 0.00
GUFICBIO.NS balance_sheet (quarterly, 2025-09-30) — Working Capital: 2575309000.00
GUFICBIO.NS income_statement (quarterly, 2025-12-31) — +Operating Expense: 1051025000.00
GUFICBIO.NS income_statement (quarterly, 2025-12-31) — +Total Revenue: 2314099000.00
GUFICBIO.NS income_statement (quarterly, 2025-12-31) — Basic Average Shares: 100190323.00
GUFICBIO.NS income_statement (quarterly, 2025-12-31) — Basic EPS: 1.24
GUFICBIO.NS income_statement (quarterly, 2025-12-31) — Cost Of Revenue: 1010217000.00
GUFICBIO.NS income_statement (quarterly, 2025-12-31) — Depreciation And Amortization In Income Statement: 76920000.00
GUFICBIO.NS income_statement (quarterly, 2025-12-31) — Depreciation Income Statement: 76920000.00
GUFICBIO.NS income_statement (quarterly, 2025-12-31) — Diluted Average Shares: 100190323.00
GUFICBIO.NS income_statement (quarterly, 2025-12-31) — Diluted EPS: 1.24
GUFICBIO.NS income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: 124236000.00
GUFICBIO.NS income_statement (quarterly, 2025-12-31) — EBIT: 260762000.00
GUFICBIO.NS income_statement (quarterly, 2025-12-31) — EBITDA: 337682000.00
GUFICBIO.NS income_statement (quarterly, 2025-12-31) — Gross Profit: 1303882000.00
GUFICBIO.NS income_statement (quarterly, 2025-12-31) — Interest Expense: 83560000.00
GUFICBIO.NS income_statement (quarterly, 2025-12-31) — Interest Expense Non Operating: 83560000.00
GUFICBIO.NS income_statement (quarterly, 2025-12-31) — Minority Interests: 0.00
GUFICBIO.NS income_statement (quarterly, 2025-12-31) — Net Income: 124236000.00
GUFICBIO.NS income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: 124236000.00
GUFICBIO.NS income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: 124236000.00
GUFICBIO.NS income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 124236000.00
GUFICBIO.NS income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 124236000.00
GUFICBIO.NS income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: 124236000.00
GUFICBIO.NS income_statement (quarterly, 2025-12-31) — Net Interest Income: -83560000.00
GUFICBIO.NS income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: -83560000.00
GUFICBIO.NS income_statement (quarterly, 2025-12-31) — Normalized EBITDA: 337682000.00
GUFICBIO.NS income_statement (quarterly, 2025-12-31) — Normalized Income: 124236000.00
GUFICBIO.NS income_statement (quarterly, 2025-12-31) — Operating Income: 252857000.00
GUFICBIO.NS income_statement (quarterly, 2025-12-31) — Operating Revenue: 2314099000.00
GUFICBIO.NS income_statement (quarterly, 2025-12-31) — Other Non Operating Income Expenses: 7905000.00
GUFICBIO.NS income_statement (quarterly, 2025-12-31) — Other Operating Expenses: 573218000.00
GUFICBIO.NS income_statement (quarterly, 2025-12-31) — Otherunder Preferred Stock Dividend: 0.00
GUFICBIO.NS income_statement (quarterly, 2025-12-31) — Pretax Income: 177202000.00
GUFICBIO.NS income_statement (quarterly, 2025-12-31) — Reconciled Cost Of Revenue: 1010217000.00
GUFICBIO.NS income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 76920000.00
GUFICBIO.NS income_statement (quarterly, 2025-12-31) — Special Income Charges: 0.00
GUFICBIO.NS income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: 0.00
GUFICBIO.NS income_statement (quarterly, 2025-12-31) — Tax Provision: 52966000.00
GUFICBIO.NS income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.30
GUFICBIO.NS income_statement (quarterly, 2025-12-31) — Total Expenses: 2061242000.00
GUFICBIO.NS income_statement (quarterly, 2025-12-31) — Total Unusual Items: 0.00
GUFICBIO.NS income_statement (quarterly, 2025-12-31) — Total Unusual Items Excluding Goodwill: 0.00
GUFICBIO.NS income_statement (annual, 2026-03-31) — +Operating Expense: 4023234000.00
GUFICBIO.NS income_statement (quarterly, 2026-03-31) — +Operating Expense: 973094000.00
GUFICBIO.NS income_statement (annual, 2026-03-31) — +Total Revenue: 9440066000.00
GUFICBIO.NS income_statement (quarterly, 2026-03-31) — +Total Revenue: 2518197000.00
GUFICBIO.NS balance_sheet (annual, 2026-03-31) — Accounts Payable: 1990278000.00
GUFICBIO.NS balance_sheet (quarterly, 2026-03-31) — Accounts Payable: 1990278000.00
GUFICBIO.NS balance_sheet (annual, 2026-03-31) — Accounts Receivable: 2973967000.00
GUFICBIO.NS balance_sheet (quarterly, 2026-03-31) — Accounts Receivable: 2973967000.00
GUFICBIO.NS balance_sheet (annual, 2026-03-31) — Available For Sale Securities: 132123000.00
GUFICBIO.NS balance_sheet (quarterly, 2026-03-31) — Available For Sale Securities: 132123000.00
GUFICBIO.NS income_statement (quarterly, 2026-03-31) — Basic Average Shares: 100440826.00
GUFICBIO.NS income_statement (quarterly, 2026-03-31) — Basic EPS: 2.18
GUFICBIO.NS cash_flow (annual, 2026-03-31) — Beginning Cash Position: 157215000.00
GUFICBIO.NS cash_flow (annual, 2026-03-31) — Capital Expenditure: -311812000.00
GUFICBIO.NS balance_sheet (annual, 2026-03-31) — Capital Lease Obligations: 195909000.00
GUFICBIO.NS balance_sheet (quarterly, 2026-03-31) — Capital Lease Obligations: 195909000.00
GUFICBIO.NS balance_sheet (annual, 2026-03-31) — Capital Stock: 100283000.00
GUFICBIO.NS balance_sheet (quarterly, 2026-03-31) — Capital Stock: 100283000.00
GUFICBIO.NS balance_sheet (annual, 2026-03-31) — Cash And Cash Equivalents: 621859000.00
GUFICBIO.NS balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 621859000.00
GUFICBIO.NS balance_sheet (annual, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 762170000.00
GUFICBIO.NS balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 762170000.00
GUFICBIO.NS cash_flow (annual, 2026-03-31) — Cash Dividends Paid: -10028000.00
GUFICBIO.NS cash_flow (annual, 2026-03-31) — Change In Inventory: -1075976000.00
GUFICBIO.NS cash_flow (annual, 2026-03-31) — Change In Payable: 362612000.00
GUFICBIO.NS cash_flow (annual, 2026-03-31) — Change In Receivables: -235939000.00
GUFICBIO.NS cash_flow (annual, 2026-03-31) — Change In Working Capital: -949303000.00
GUFICBIO.NS cash_flow (annual, 2026-03-31) — Changes In Cash: 464644000.00
GUFICBIO.NS balance_sheet (annual, 2026-03-31) — Common Stock: 100283000.00
GUFICBIO.NS balance_sheet (quarterly, 2026-03-31) — Common Stock: 100283000.00
GUFICBIO.NS balance_sheet (annual, 2026-03-31) — Common Stock Equity: 6649486000.00
GUFICBIO.NS balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 6649486000.00
GUFICBIO.NS cash_flow (annual, 2026-03-31) — Common Stock Issuance: 2747000.00
GUFICBIO.NS balance_sheet (annual, 2026-03-31) — Construction In Progress: 221446000.00
GUFICBIO.NS balance_sheet (quarterly, 2026-03-31) — Construction In Progress: 221446000.00
GUFICBIO.NS income_statement (annual, 2026-03-31) — Cost Of Revenue: 4211802000.00
GUFICBIO.NS income_statement (quarterly, 2026-03-31) — Cost Of Revenue: 1149487000.00
GUFICBIO.NS balance_sheet (annual, 2026-03-31) — Current Assets: 8021153000.00
GUFICBIO.NS balance_sheet (quarterly, 2026-03-31) — Current Assets: 8021153000.00
GUFICBIO.NS balance_sheet (annual, 2026-03-31) — Current Capital Lease Obligation: 52179000.00
GUFICBIO.NS balance_sheet (quarterly, 2026-03-31) — Current Capital Lease Obligation: 52179000.00
GUFICBIO.NS balance_sheet (annual, 2026-03-31) — Current Debt: 2801269000.00
GUFICBIO.NS balance_sheet (quarterly, 2026-03-31) — Current Debt: 2801269000.00
GUFICBIO.NS balance_sheet (annual, 2026-03-31) — Current Debt And Capital Lease Obligation: 2853448000.00
GUFICBIO.NS balance_sheet (quarterly, 2026-03-31) — Current Debt And Capital Lease Obligation: 2853448000.00
GUFICBIO.NS balance_sheet (annual, 2026-03-31) — Current Liabilities: 5178490000.00
GUFICBIO.NS balance_sheet (quarterly, 2026-03-31) — Current Liabilities: 5178490000.00
GUFICBIO.NS balance_sheet (annual, 2026-03-31) — Current Provisions: 45441000.00
GUFICBIO.NS balance_sheet (quarterly, 2026-03-31) — Current Provisions: 45441000.00
GUFICBIO.NS cash_flow (annual, 2026-03-31) — Deferred Tax: 223363000.00
GUFICBIO.NS cash_flow (annual, 2026-03-31) — Depreciation: 308326000.00
GUFICBIO.NS cash_flow (annual, 2026-03-31) — Depreciation And Amortization: 308326000.00
GUFICBIO.NS income_statement (annual, 2026-03-31) — Depreciation And Amortization In Income Statement: 308326000.00
GUFICBIO.NS income_statement (quarterly, 2026-03-31) — Depreciation And Amortization In Income Statement: 76487000.00
GUFICBIO.NS income_statement (annual, 2026-03-31) — Depreciation Income Statement: 308326000.00
GUFICBIO.NS income_statement (quarterly, 2026-03-31) — Depreciation Income Statement: 76487000.00
GUFICBIO.NS income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 100440826.00
GUFICBIO.NS income_statement (quarterly, 2026-03-31) — Diluted EPS: 2.18
GUFICBIO.NS income_statement (annual, 2026-03-31) — Diluted NI Availto Com Stockholders: 642147000.00
GUFICBIO.NS income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: 218961000.00
GUFICBIO.NS cash_flow (annual, 2026-03-31) — Dividends Received Cfi: 4000.00
GUFICBIO.NS income_statement (annual, 2026-03-31) — EBIT: 1231604000.00
GUFICBIO.NS income_statement (quarterly, 2026-03-31) — EBIT: 383879000.00
GUFICBIO.NS income_statement (annual, 2026-03-31) — EBITDA: 1539930000.00
GUFICBIO.NS income_statement (quarterly, 2026-03-31) — EBITDA: 460366000.00
GUFICBIO.NS cash_flow (annual, 2026-03-31) — End Cash Position: 621859000.00
GUFICBIO.NS cash_flow (annual, 2026-03-31) — Financing Cash Flow: 324608000.00
GUFICBIO.NS cash_flow (annual, 2026-03-31) — Free Cash Flow: 137866000.00
GUFICBIO.NS cash_flow (annual, 2026-03-31) — Gain Loss On Investment Securities: 36000.00
GUFICBIO.NS cash_flow (annual, 2026-03-31) — Gain Loss On Sale Of PPE: 0.00
GUFICBIO.NS balance_sheet (annual, 2026-03-31) — Goodwill And Other Intangible Assets: 61637000.00
GUFICBIO.NS balance_sheet (quarterly, 2026-03-31) — Goodwill And Other Intangible Assets: 61637000.00
GUFICBIO.NS balance_sheet (annual, 2026-03-31) — Gross PPE: 5069972000.00
GUFICBIO.NS balance_sheet (quarterly, 2026-03-31) — Gross PPE: 5069972000.00
GUFICBIO.NS income_statement (annual, 2026-03-31) — Gross Profit: 5228264000.00
GUFICBIO.NS income_statement (quarterly, 2026-03-31) — Gross Profit: 1368710000.00
GUFICBIO.NS income_statement (annual, 2026-03-31) — Interest Expense: 366114000.00
GUFICBIO.NS income_statement (quarterly, 2026-03-31) — Interest Expense: 94373000.00
GUFICBIO.NS income_statement (annual, 2026-03-31) — Interest Expense Non Operating: 366114000.00
GUFICBIO.NS income_statement (quarterly, 2026-03-31) — Interest Expense Non Operating: 94373000.00
GUFICBIO.NS cash_flow (annual, 2026-03-31) — Interest Paid Cff: -328064000.00
GUFICBIO.NS cash_flow (annual, 2026-03-31) — Interest Received Cfi: 10087000.00
GUFICBIO.NS balance_sheet (annual, 2026-03-31) — Inventory: 3244666000.00
GUFICBIO.NS balance_sheet (quarterly, 2026-03-31) — Inventory: 3244666000.00
GUFICBIO.NS balance_sheet (annual, 2026-03-31) — Invested Capital: 10501110000.00
GUFICBIO.NS balance_sheet (quarterly, 2026-03-31) — Invested Capital: 10501110000.00
GUFICBIO.NS cash_flow (annual, 2026-03-31) — Investing Cash Flow: -309642000.00
GUFICBIO.NS balance_sheet (annual, 2026-03-31) — Investmentin Financial Assets: 132123000.00
GUFICBIO.NS balance_sheet (quarterly, 2026-03-31) — Investmentin Financial Assets: 132123000.00
GUFICBIO.NS cash_flow (annual, 2026-03-31) — Issuance Of Capital Stock: 2747000.00
GUFICBIO.NS balance_sheet (annual, 2026-03-31) — Long Term Capital Lease Obligation: 143730000.00
GUFICBIO.NS balance_sheet (quarterly, 2026-03-31) — Long Term Capital Lease Obligation: 143730000.00
GUFICBIO.NS balance_sheet (annual, 2026-03-31) — Long Term Debt: 1050355000.00
GUFICBIO.NS balance_sheet (quarterly, 2026-03-31) — Long Term Debt: 1050355000.00
GUFICBIO.NS balance_sheet (annual, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 1194085000.00
GUFICBIO.NS balance_sheet (quarterly, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 1194085000.00
GUFICBIO.NS balance_sheet (annual, 2026-03-31) — Long Term Provisions: 180027000.00
GUFICBIO.NS balance_sheet (quarterly, 2026-03-31) — Long Term Provisions: 180027000.00
GUFICBIO.NS balance_sheet (annual, 2026-03-31) — Minority Interest: 381000.00
GUFICBIO.NS balance_sheet (quarterly, 2026-03-31) — Minority Interest: 381000.00
GUFICBIO.NS income_statement (annual, 2026-03-31) — Minority Interests: 20000.00
GUFICBIO.NS income_statement (quarterly, 2026-03-31) — Minority Interests: 0.00
GUFICBIO.NS cash_flow (annual, 2026-03-31) — Net Business Purchase And Sale: -614000.00
GUFICBIO.NS cash_flow (annual, 2026-03-31) — Net Common Stock Issuance: 2747000.00
GUFICBIO.NS balance_sheet (annual, 2026-03-31) — Net Debt: 3229765000.00
GUFICBIO.NS balance_sheet (quarterly, 2026-03-31) — Net Debt: 3229765000.00
GUFICBIO.NS income_statement (annual, 2026-03-31) — Net Income: 642147000.00
GUFICBIO.NS income_statement (quarterly, 2026-03-31) — Net Income: 218961000.00
GUFICBIO.NS income_statement (annual, 2026-03-31) — Net Income Common Stockholders: 642147000.00
GUFICBIO.NS income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: 218961000.00
GUFICBIO.NS income_statement (annual, 2026-03-31) — Net Income Continuous Operations: 642127000.00
GUFICBIO.NS income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: 218961000.00
GUFICBIO.NS income_statement (annual, 2026-03-31) — Net Income From Continuing And Discontinued Operation: 642147000.00
GUFICBIO.NS income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: 218961000.00
GUFICBIO.NS income_statement (annual, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: 642147000.00
GUFICBIO.NS income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: 218961000.00
GUFICBIO.NS cash_flow (annual, 2026-03-31) — Net Income From Continuing Operations: 642127000.00
GUFICBIO.NS income_statement (annual, 2026-03-31) — Net Income Including Noncontrolling Interests: 642127000.00
GUFICBIO.NS income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: 218961000.00
GUFICBIO.NS income_statement (annual, 2026-03-31) — Net Interest Income: -366114000.00
GUFICBIO.NS income_statement (quarterly, 2026-03-31) — Net Interest Income: -94373000.00
GUFICBIO.NS cash_flow (annual, 2026-03-31) — Net Issuance Payments Of Debt: 747878000.00
GUFICBIO.NS cash_flow (annual, 2026-03-31) — Net Long Term Debt Issuance: -254641000.00
GUFICBIO.NS income_statement (annual, 2026-03-31) — Net Non Operating Interest Income Expense: -366114000.00
GUFICBIO.NS income_statement (quarterly, 2026-03-31) — Net Non Operating Interest Income Expense: -94373000.00
GUFICBIO.NS cash_flow (annual, 2026-03-31) — Net Other Financing Charges: -2125000.00
GUFICBIO.NS cash_flow (annual, 2026-03-31) — Net Other Investing Changes: -7322000.00
GUFICBIO.NS balance_sheet (annual, 2026-03-31) — Net PPE: 5069972000.00
GUFICBIO.NS balance_sheet (quarterly, 2026-03-31) — Net PPE: 5069972000.00
GUFICBIO.NS cash_flow (annual, 2026-03-31) — Net PPE Purchase And Sale: -311797000.00
GUFICBIO.NS cash_flow (annual, 2026-03-31) — Net Short Term Debt Issuance: 1002519000.00
GUFICBIO.NS balance_sheet (annual, 2026-03-31) — Net Tangible Assets: 6587849000.00
GUFICBIO.NS balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: 6587849000.00
GUFICBIO.NS balance_sheet (annual, 2026-03-31) — Non Current Deferred Taxes Liabilities: 165735000.00
GUFICBIO.NS balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Taxes Liabilities: 165735000.00
GUFICBIO.NS income_statement (annual, 2026-03-31) — Normalized EBITDA: 1539930000.00
GUFICBIO.NS income_statement (quarterly, 2026-03-31) — Normalized EBITDA: 460366000.00
GUFICBIO.NS income_statement (annual, 2026-03-31) — Normalized Income: 642147000.00
GUFICBIO.NS income_statement (quarterly, 2026-03-31) — Normalized Income: 218961000.00
GUFICBIO.NS cash_flow (annual, 2026-03-31) — Operating Cash Flow: 449678000.00
GUFICBIO.NS income_statement (annual, 2026-03-31) — Operating Income: 1205030000.00
GUFICBIO.NS income_statement (quarterly, 2026-03-31) — Operating Income: 395616000.00
GUFICBIO.NS income_statement (annual, 2026-03-31) — Operating Revenue: 9440066000.00
GUFICBIO.NS income_statement (quarterly, 2026-03-31) — Operating Revenue: 2518197000.00
GUFICBIO.NS balance_sheet (annual, 2026-03-31) — Ordinary Shares Number: 100282506.00
GUFICBIO.NS balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 100282506.00
GUFICBIO.NS balance_sheet (annual, 2026-03-31) — Other Current Assets: 1018025000.00
GUFICBIO.NS balance_sheet (quarterly, 2026-03-31) — Other Current Assets: 1018025000.00
GUFICBIO.NS balance_sheet (annual, 2026-03-31) — Other Current Liabilities: 110484000.00
GUFICBIO.NS balance_sheet (quarterly, 2026-03-31) — Other Current Liabilities: 110484000.00
GUFICBIO.NS balance_sheet (annual, 2026-03-31) — Other Equity Interest: 6549203000.00
GUFICBIO.NS balance_sheet (quarterly, 2026-03-31) — Other Equity Interest: 6549203000.00
GUFICBIO.NS cash_flow (annual, 2026-03-31) — Other Non Cash Items: 343544000.00
GUFICBIO.NS balance_sheet (annual, 2026-03-31) — Other Non Current Assets: 133634000.00
GUFICBIO.NS balance_sheet (quarterly, 2026-03-31) — Other Non Current Assets: 133634000.00
GUFICBIO.NS income_statement (annual, 2026-03-31) — Other Non Operating Income Expenses: 26574000.00
GUFICBIO.NS income_statement (quarterly, 2026-03-31) — Other Non Operating Income Expenses: -11737000.00
GUFICBIO.NS income_statement (annual, 2026-03-31) — Other Operating Expenses: 2198100000.00
GUFICBIO.NS income_statement (quarterly, 2026-03-31) — Other Operating Expenses: 515160000.00
GUFICBIO.NS balance_sheet (annual, 2026-03-31) — Other Properties: 4848526000.00
GUFICBIO.NS balance_sheet (quarterly, 2026-03-31) — Other Properties: 4848526000.00
GUFICBIO.NS balance_sheet (annual, 2026-03-31) — Other Receivables: 6614000.00
GUFICBIO.NS balance_sheet (quarterly, 2026-03-31) — Other Receivables: 6614000.00
GUFICBIO.NS balance_sheet (annual, 2026-03-31) — Other Short Term Investments: 140311000.00
GUFICBIO.NS balance_sheet (quarterly, 2026-03-31) — Other Short Term Investments: 140311000.00
GUFICBIO.NS income_statement (annual, 2026-03-31) — Otherunder Preferred Stock Dividend: 0.00
GUFICBIO.NS income_statement (quarterly, 2026-03-31) — Otherunder Preferred Stock Dividend: 0.00
GUFICBIO.NS balance_sheet (annual, 2026-03-31) — Payables: 2008888000.00
GUFICBIO.NS balance_sheet (quarterly, 2026-03-31) — Payables: 2008888000.00
GUFICBIO.NS income_statement (annual, 2026-03-31) — Pretax Income: 865490000.00
GUFICBIO.NS income_statement (quarterly, 2026-03-31) — Pretax Income: 289506000.00
GUFICBIO.NS cash_flow (annual, 2026-03-31) — Purchase Of Business: -614000.00
GUFICBIO.NS cash_flow (annual, 2026-03-31) — Purchase Of PPE: -311812000.00
GUFICBIO.NS income_statement (annual, 2026-03-31) — Reconciled Cost Of Revenue: 4211802000.00
GUFICBIO.NS income_statement (quarterly, 2026-03-31) — Reconciled Cost Of Revenue: 1149487000.00
GUFICBIO.NS income_statement (annual, 2026-03-31) — Reconciled Depreciation: 308326000.00
GUFICBIO.NS income_statement (quarterly, 2026-03-31) — Reconciled Depreciation: 76487000.00
GUFICBIO.NS cash_flow (annual, 2026-03-31) — Sale Of Business: 0.00
GUFICBIO.NS cash_flow (annual, 2026-03-31) — Sale Of PPE: 15000.00
GUFICBIO.NS balance_sheet (annual, 2026-03-31) — Share Issued: 100282506.00
GUFICBIO.NS balance_sheet (quarterly, 2026-03-31) — Share Issued: 100282506.00
GUFICBIO.NS income_statement (annual, 2026-03-31) — Special Income Charges: 0.00
GUFICBIO.NS income_statement (quarterly, 2026-03-31) — Special Income Charges: 0.00
GUFICBIO.NS balance_sheet (annual, 2026-03-31) — Stockholders Equity: 6649486000.00
GUFICBIO.NS balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: 6649486000.00
GUFICBIO.NS balance_sheet (annual, 2026-03-31) — Tangible Book Value: 6587849000.00
GUFICBIO.NS balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: 6587849000.00
GUFICBIO.NS income_statement (annual, 2026-03-31) — Tax Effect Of Unusual Items: 0.00
GUFICBIO.NS income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: 0.00
GUFICBIO.NS income_statement (annual, 2026-03-31) — Tax Provision: 223363000.00
GUFICBIO.NS income_statement (quarterly, 2026-03-31) — Tax Provision: 70545000.00
GUFICBIO.NS income_statement (annual, 2026-03-31) — Tax Rate For Calcs: 0.26
GUFICBIO.NS income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.24
GUFICBIO.NS balance_sheet (annual, 2026-03-31) — Taxes Receivable: 15711000.00
GUFICBIO.NS balance_sheet (quarterly, 2026-03-31) — Taxes Receivable: 15711000.00
GUFICBIO.NS cash_flow (annual, 2026-03-31) — Taxes Refund Paid: -118415000.00
GUFICBIO.NS balance_sheet (annual, 2026-03-31) — Total Assets: 13423740000.00
GUFICBIO.NS balance_sheet (quarterly, 2026-03-31) — Total Assets: 13423740000.00
GUFICBIO.NS balance_sheet (annual, 2026-03-31) — Total Capitalization: 7699841000.00
GUFICBIO.NS balance_sheet (quarterly, 2026-03-31) — Total Capitalization: 7699841000.00
GUFICBIO.NS balance_sheet (annual, 2026-03-31) — Total Debt: 4047533000.00
GUFICBIO.NS balance_sheet (quarterly, 2026-03-31) — Total Debt: 4047533000.00
GUFICBIO.NS balance_sheet (annual, 2026-03-31) — Total Equity Gross Minority Interest: 6649867000.00
GUFICBIO.NS balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: 6649867000.00
GUFICBIO.NS income_statement (annual, 2026-03-31) — Total Expenses: 8235036000.00
GUFICBIO.NS income_statement (quarterly, 2026-03-31) — Total Expenses: 2122581000.00
GUFICBIO.NS balance_sheet (annual, 2026-03-31) — Total Liabilities Net Minority Interest: 6773873000.00
GUFICBIO.NS balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 6773873000.00
GUFICBIO.NS balance_sheet (annual, 2026-03-31) — Total Non Current Assets: 5402588000.00
GUFICBIO.NS balance_sheet (quarterly, 2026-03-31) — Total Non Current Assets: 5402588000.00
GUFICBIO.NS balance_sheet (annual, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 1595383000.00
GUFICBIO.NS balance_sheet (quarterly, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 1595383000.00
GUFICBIO.NS balance_sheet (annual, 2026-03-31) — Total Tax Payable: 18610000.00
GUFICBIO.NS balance_sheet (quarterly, 2026-03-31) — Total Tax Payable: 18610000.00
GUFICBIO.NS income_statement (annual, 2026-03-31) — Total Unusual Items: 0.00
GUFICBIO.NS income_statement (quarterly, 2026-03-31) — Total Unusual Items: 0.00
GUFICBIO.NS income_statement (annual, 2026-03-31) — Total Unusual Items Excluding Goodwill: 0.00
GUFICBIO.NS income_statement (quarterly, 2026-03-31) — Total Unusual Items Excluding Goodwill: 0.00
GUFICBIO.NS balance_sheet (annual, 2026-03-31) — Working Capital: 2842663000.00
GUFICBIO.NS balance_sheet (quarterly, 2026-03-31) — Working Capital: 2842663000.00
GUG balance_sheet (annual, 2022-05-31) — Accounts Payable: 3251430.00
GUG balance_sheet (annual, 2022-05-31) — Additional Paid In Capital: 659216223.00
GUG balance_sheet (annual, 2022-05-31) — Capital Stock: 329801.00
GUG balance_sheet (annual, 2022-05-31) — Cash And Cash Equivalents: 152020.00
GUG balance_sheet (annual, 2022-05-31) — Cash Cash Equivalents And Federal Funds Sold: 427020.00
GUG balance_sheet (annual, 2022-05-31) — Cash Financial: 152020.00
GUG balance_sheet (annual, 2022-05-31) — Common Stock: 329801.00
GUG balance_sheet (annual, 2022-05-31) — Common Stock Equity: 575323330.00
GUG balance_sheet (annual, 2022-05-31) — Derivative Product Liabilities: 6919780.00
GUG balance_sheet (annual, 2022-05-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 806277006.00
GUG balance_sheet (annual, 2022-05-31) — Invested Capital: 823508434.00
GUG balance_sheet (annual, 2022-05-31) — Investmentin Financial Assets: 808490230.00
GUG balance_sheet (annual, 2022-05-31) — Investments And Advances: 808490230.00
GUG balance_sheet (annual, 2022-05-31) — Long Term Debt And Capital Lease Obligation: 248185104.00
GUG balance_sheet (annual, 2022-05-31) — Net Debt: 248033084.00
GUG balance_sheet (annual, 2022-05-31) — Net Tangible Assets: 575323330.00
GUG balance_sheet (annual, 2022-05-31) — Ordinary Shares Number: 32980083.00
GUG balance_sheet (annual, 2022-05-31) — Other Payable: 3275478.00
GUG balance_sheet (annual, 2022-05-31) — Payables: 6526908.00
GUG balance_sheet (annual, 2022-05-31) — Prepaid Assets: 15030.00
GUG balance_sheet (annual, 2022-05-31) — Receivables: 28117118.00
GUG balance_sheet (annual, 2022-05-31) — Retained Earnings: -84222694.00
GUG balance_sheet (annual, 2022-05-31) — Share Issued: 32980083.00
GUG balance_sheet (annual, 2022-05-31) — Stockholders Equity: 575323330.00
GUG balance_sheet (annual, 2022-05-31) — Tangible Book Value: 575323330.00
GUG balance_sheet (annual, 2022-05-31) — Total Assets: 837049398.00
GUG balance_sheet (annual, 2022-05-31) — Total Capitalization: 823508434.00
GUG balance_sheet (annual, 2022-05-31) — Total Debt: 248185104.00
GUG balance_sheet (annual, 2022-05-31) — Total Equity Gross Minority Interest: 575323330.00
GUG balance_sheet (annual, 2022-05-31) — Total Liabilities Net Minority Interest: 261726068.00
GUG income_statement (annual, 2023-05-31) — +Operating Expense: 987169.00
GUG income_statement (annual, 2023-05-31) — +Total Revenue: -6129302.00
GUG balance_sheet (annual, 2023-05-31) — Accounts Payable: 1149373.00
GUG balance_sheet (annual, 2023-05-31) — Additional Paid In Capital: 648599978.00
GUG income_statement (annual, 2023-05-31) — Basic Average Shares: 33887957.00
GUG income_statement (annual, 2023-05-31) — Basic EPS: -0.21
GUG cash_flow (annual, 2023-05-31) — Beginning Cash Position: 427020.00
GUG balance_sheet (annual, 2023-05-31) — Capital Stock: 329801.00
GUG balance_sheet (annual, 2023-05-31) — Cash And Cash Equivalents: 437351.00
GUG balance_sheet (annual, 2023-05-31) — Cash Cash Equivalents And Federal Funds Sold: 1400652.00
GUG cash_flow (annual, 2023-05-31) — Cash Dividends Paid: -46996618.00
GUG balance_sheet (annual, 2023-05-31) — Cash Financial: 437351.00
GUG cash_flow (annual, 2023-05-31) — Change In Other Current Assets: 511469.00
GUG cash_flow (annual, 2023-05-31) — Change In Other Current Liabilities: 482910.00
GUG cash_flow (annual, 2023-05-31) — Change In Payable: -3589419.00
GUG cash_flow (annual, 2023-05-31) — Change In Prepaid Assets: 2091.00
GUG cash_flow (annual, 2023-05-31) — Change In Receivables: 19768965.00
GUG cash_flow (annual, 2023-05-31) — Change In Working Capital: 17176016.00
GUG cash_flow (annual, 2023-05-31) — Changes In Cash: 973632.00
GUG balance_sheet (annual, 2023-05-31) — Common Stock: 329801.00
GUG cash_flow (annual, 2023-05-31) — Common Stock Dividend Paid: -46996618.00
GUG balance_sheet (annual, 2023-05-31) — Common Stock Equity: 521215360.00
GUG balance_sheet (annual, 2023-05-31) — Derivative Product Liabilities: 2290672.00
GUG income_statement (annual, 2023-05-31) — Diluted Average Shares: 33887957.00
GUG income_statement (annual, 2023-05-31) — Diluted EPS: -0.21
GUG income_statement (annual, 2023-05-31) — Diluted NI Availto Com Stockholders: -7116471.00
GUG cash_flow (annual, 2023-05-31) — Dividend Received Cfo: 1084.00
GUG cash_flow (annual, 2023-05-31) — End Cash Position: 1400652.00
GUG balance_sheet (annual, 2023-05-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 711154446.00
GUG cash_flow (annual, 2023-05-31) — Financing Cash Flow: -98613222.00
GUG cash_flow (annual, 2023-05-31) — Free Cash Flow: 99586854.00
GUG cash_flow (annual, 2023-05-31) — Gain Loss On Investment Securities: 91130522.00
GUG income_statement (annual, 2023-05-31) — Gain On Sale Of Security: -1043330.00
GUG income_statement (annual, 2023-05-31) — General And Administrative Expense: 1007221.00
GUG income_statement (annual, 2023-05-31) — Interest Expense: 8265023.00
GUG income_statement (annual, 2023-05-31) — Interest Income: 40780589.00
GUG balance_sheet (annual, 2023-05-31) — Invested Capital: 717725235.00
GUG balance_sheet (annual, 2023-05-31) — Investmentin Financial Assets: 713567900.00
GUG balance_sheet (annual, 2023-05-31) — Investments And Advances: 713567900.00
GUG cash_flow (annual, 2023-05-31) — Issuance Of Debt: 593507733.00
GUG balance_sheet (annual, 2023-05-31) — Long Term Debt And Capital Lease Obligation: 196509875.00
GUG cash_flow (annual, 2023-05-31) — Long Term Debt Issuance: 593507733.00
GUG cash_flow (annual, 2023-05-31) — Long Term Debt Payments: -645129456.00
GUG balance_sheet (annual, 2023-05-31) — Net Debt: 196072524.00
GUG income_statement (annual, 2023-05-31) — Net Income: -7116471.00
GUG income_statement (annual, 2023-05-31) — Net Income Common Stockholders: -7116471.00
GUG income_statement (annual, 2023-05-31) — Net Income Continuous Operations: -7116471.00
GUG income_statement (annual, 2023-05-31) — Net Income From Continuing And Discontinued Operation: -7116471.00
GUG income_statement (annual, 2023-05-31) — Net Income From Continuing Operation Net Minority Interest: -7116471.00
GUG cash_flow (annual, 2023-05-31) — Net Income From Continuing Operations: -7116471.00
GUG income_statement (annual, 2023-05-31) — Net Income Including Noncontrolling Interests: -7116471.00